Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

By Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed

Articles by By Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed

Back to the Future: Psychedelics and a Return to the Concept of Recovery in Psychiatry

ByBy Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed

September 26th 2022

Latest Updated Articles

Back to the Future: Psychedelics and a Return to the Concept of Recovery in Psychiatry
September 26th 2022

Trending on Psychiatric Times

Burnout, Gratitude, and the Value of Staying Current: On the Mind of Gus Alva, MD, DFAPA

Food Noise and GLP-1 Drugs: What Research Reveals About Motivation and Appetitive Drive

Daridorexant, Orexin Receptor Agonist, Shows Positive Results in Pediatric Insomnia

Dementia Pipeline Update: Phase 2 and 3 Developments in Alzheimer Disease and Lewy Body Dementia

Neflamapimod for Dementia With Lewy Bodies Misses End Point, Subgroup Signal Emerges